Glaukos Products to be Subject of Multiple Presentations at American Academy of Ophthalmology Annual Meeting
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its products will be included in various presentations at the American Academy of Ophthalmology (AAO) annual meeting, which begins Saturday, October 12, 2019 at the Moscone Center in San Francisco, CA. Key presentations include: Saturday, October